NIDDK Central Repository - Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.7326/0003-4819-141-8-200410190-00005

PubMed ID

15492337

Public Release Type

Journal

Publication Year

2004

Affiliation

Veterans Affairs Maryland Health Care System and University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. ralexander@smail.umaryland.edu

Authors

Alexander RB, Chronic Prostatitis Collaborative Research Network, Comiter CV, Datta NS, Fowler JE Jr, Knauss JS, Kusek JW, Landis JR, Litwin MS, McNaughton-Collins M, Nadler RB, Nickel JC, Nyberg LM Jr, O'Leary MP, Pontari MA, Propert KJ, Schaeffer AJ, Shoskes DA, Wang Y, Zeitlin SI

Citation

Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE Jr, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM Jr, Litwin MS, Chronic Prostatitis Collaborative Research Network. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004 Oct 19;141(8):581-9.

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men is principally defined by pain in the pelvic region lasting more than 3 months. No cause of the disease has been established, and therapies are empirical and mostly untested. Antimicrobial agents and alpha-adrenergic receptor blockers are frequently used.